NEW YORK (GenomeWeb) – Roche announced on Sunday the expansion of its HIV Global Access Program to include early infant HIV diagnostic testing in resource-limited settings.
The HIV Global Access Program was launched in 2014 to increase access to Roche's cobas AmpliPrep/cobas TaqMan HIV-1 Test version 2.0 through special pricing provided to qualifying organizations in eligible countries.